Heart Disease
Merck's Oral PCSK9 Inhibitor Shows Significant LDL-C Reductions
Enlicitide Decanoate demonstrated greater efficacy in lowering LDL cholesterol compared to placebo in clinical trials.
Top Cardiologist Shares Nighttime Habits to Reduce Heart Disease Risk
Dr. Cynthia Kos offers advice on common bedtime mistakes that can impact cardiovascular health.
Positive Data from Phase 2 CADENCE Trial Proves Sotatercept-csrk Effective
Biotech firm announces promising results for new treatment targeting adults with pulmonary arterial hypertension.
- Congresswoman Fights Prosecution Over ICE Facility Incident
- New Jersey Expands Practice Authority for Advanced Practice Nurses
- Bruce Springsteen's Jeopardy! Trivia Dominance
- New Jersey Fights to Keep Medicaid Enrollees Covered Amid Federal Changes
- Somers Point, NJ Announces Stellar 2026 Summer Concert Lineup
- Newark Mourns Passing of Beloved Community Leader Al Coutinho